Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial

EuroIntervention

Volumn 10, Issue 4, 2014, Pages 449-457

  Ishibashi, Yuki ^a   Onuma, Yoshinobu ^a   Muramatsu, Takashi ^a   Nakatani, Shimpei ^a   Iqbal, Javaid ^a   Garcia Garcia, Hector M ^a   Bartorelli, Antonio L ^b   Whitbourn, Robert ^c   Abizaid, Alexander ^d   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MILAN   (Italy)

^c ST VINCENT S HOSPITAL   (Australia)

^d Dante Pazzanese Hospital   (Brazil)

Author keywords

Bioresorbable scaffold; Scaffold dislodgement; Scaffold thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON DILATATION; BIORESORBABLE SCAFFOLD; CLINICAL TRIAL (TOPIC); CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEVICE FAILURE; DEVICE REMOVAL; EVEROLIMUS ELUTING CORONARY STENT; FIBRINOLYTIC THERAPY; GUIDING CATHETER; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEDICAL DEVICE COMPLICATION; MEDICATION COMPLIANCE; METAL STENT; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; SCAFFOLD DISLODGEMENT; SCAFFOLD THROMBOSIS; SNARE WIRE; STENT THROMBOSIS; SUDDEN DEATH; THROMBECTOMY; THROMBOSIS; VASCULAR GUIDE WIRE; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; CORONARY RESTENOSIS; DRUG ELUTING STENT; FEMALE; MALE; MIDDLE AGED; PROCEDURES; PROSTHESIS; TISSUE SCAFFOLD; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84903621793     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10I4A78     Document Type: Article

References (24)

1. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis. Biological mechanisms and clinical implications. Circulation. 2007;115:1051-8.
2. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426-34.
3. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation. 2003;108:1701-6.
4. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-30.
5. Onuma Y, Serruys PW, Ormiston JA, Regar E, Webster M, Thuesen L, Dudek D, Veldhof S, Rapoza R. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention. 2010;6:447-53.
6. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, de Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol. 2011;58:1578-88.
7. Dudek D, Onuma Y, Ormiston JA, Thuesen L, Miquel-Hebert K, Serruys PW. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention. 2012;7:1060-1.
8. Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, García-García HM, Regar E, Kamberi M, Powers JC, Rapoza R, van Beusekom H, van der Giessen W, Virmani R. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation. 2010;122:2288-300.
9. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, García-García HM. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122:2301-12.
10. Oberhauser JP, Hossainy S, Rapoza R. Design principles and performance of bioresorbable polymeric vascular scaffolds. EuroIntervention. 2009;5:F15-22.
11. Muramatsu T, Onuma Y, García-García HM, Farooq V, Bourantas CV, Morel MA, Li X, Veldhof S, Bartorelli A, Whitbourn R, Abizaid A, Serruys PW; ABSORB-EXTEND Investigators. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv. 2013;6:247-57.
12. Kwan TW, Chaudhry M, Huang Y, Liou M, Wong S, Zhou X, Pancholy S, Patel T. Approaches for dislodged stent retrieval during transradial percutaneous coronary interventions. Catheter Cardiovasc Interv. 2013;81:E245-9.
13. Curran PJ, Currier J, Tobis J. Percutaneous snare retrieval of a partially embedded Wallstent. Catheter Cardiovasc Interv. 2004;61:400-2.
14. Eggebrecht H, Haude M, von Birgelen C, Oldenburg O, Baumgart D, Herrmann J, Welge D, Bartel T, Dagres N, Erbel R. Nonsurgical retrieval of embolized coronary stents. Catheter Cardiovasc Interv. 2000;51:432-40.
15. Webb JG, Solankhi N, Carere RG. Facilitation of stent retention and retrieval with an emboli containment device. Catheter Cardiovasc Interv. 2000;50:215-7.
16. Laarman G, Muthusamy TS, Swart H, Westendorp I, Kiemeneij F, Slagboom T, van der Wieken R. Direct coronary stent implantation: safety, feasibility and predictors of success of the strategy of direct coronary stent implantation. Catheter Cardiovasc Interv. 2001;52:443-8.
17. Okamura T, Garg S, Gutiérrez-Chico JL, Shin ES, Onuma Y, García-García HM, Rapoza RJ, Sudhir K, Regar E, Serruys PW. In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial. EuroIntervention. 2010;5:932-8.
18. Byrne RA, Kastrati A, Massberg S, Wieczorek A, Laugwitz KL, Hadamitzky M, Schulz S, Pache J, Fusaro M, Hausleiter J, Schömig A, Mehilli J; ISAR-TEST 4 Investigators. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial. J Am Coll Cardiol. 2011;58:1325-31.
19. Seifert B, Romaniuk P, Groth TH. Bioresorbable, heparinized polymers for stent coating: in vitro studies on heparinization efficiency, maintenance of anticoagulant properties and improvement of stent haemocompatibility. J Mater Sci Mater Med. 1996;7:465-9.
20. Onuma Y, Serruys PW. The advent of a new era in percutaneous coronary and peripheral revascularization? Circulation. 2011;123:779-97.
21. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-78.
22. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115:1051-8.
23. Farooq V, Serruys PW, Heo JH, Gogas BD, Onuma Y, Perkins LE, Diletti R, Radu MD, Räber L, Bourantas CV, Zhang Y, van Remortel E, Pawar R, Rapoza RJ, Powers JC, van Beusekom HM, Garcìa-Garcìa HM, Virmani R. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. JACC Cardiovasc Interv. 2013;6:523-32.
24. Kounis NG, Giannopoulos S, Tsigkas GG, Goudevenos J. Eosinophilic responses to stent implantation and the risk of Kounis hypersensitivity associated coronary syndrome. Int J Cardiol. 2012;156:125-32.